Skeletal Dynamics Jobs (NOW HIRING)

Are you an experienced Associate Director Value & Access Strategy Skeletal Conditions with a desire to excel? If so, then Talent Software Services may have the job for you! Our client is seeking an experienced Associate Director Value & Access Strategy Skeletal Conditions to work at their company in Novato, California.

The Opportunity

We are seeking a US Market Access Launch Readiness Support Contractor to shape and deliver critical pre-launch market access deliverables for the Hypochondroplasia (HCH) launch, while ensuring strategic alignment across our broader skeletal conditions portfolio, including Achondroplasia (ACH).

This is a high-impact role demanding both strategic thinking and disciplined execution. As a key partner to the Senior Director, you will provide coordination oversight, cross-functional leadership, and direct execution accountability to secure Day-1 access for Voxzogo in the HCH indication.

Core Responsibilities

1. Launch Readiness Project Management

•Orchestrate the US Market Access HCH Launch workplan, driving milestone accountability across all workstreams — from payer readiness to Day-1 patient support services activation.

•Actively manage the launch critical path, identifying execution risks and leading mitigation efforts to protect Day-1 access commitments.

•Serve as the central coordination point across internal teams and external partners, ensuring workstream interdependencies are visible and managed proactively.

•Maintain a launch readiness dashboard to provide real-time visibility into workstream progress, milestone status, and risk flags, enabling rapid decision-making.

2.Payer Value & Asset Development

•Support the development and refinement of the Pre-Approval Payer Value Deck, synthesizing complex clinical and economic evidence into a clear, compelling narrative for payer engagements to ensure payer readiness.

•Manage the end-to-end MMRC/PRB submission and review process for all payer-facing HCH assets.

•Support strategic material development, logistical oversight, and insight synthesis for the upcoming Payer Ad Board in collaboration with external vendors and internal stakeholders.

3. Launch Readiness Pull-through

•Oversee operational alignment across V&A Strategy, Patient Support Services, Pricing & Contracting, and Distribution Channels team to ensure frictionless access for providers and patients upon product launch.

•Oversee pull-through readiness across payers, providers, hubs, specialty pharmacies, and distributors — ensuring no gaps at the point of patient access.

•Serve as a hands-on strategic resource for ad-hoc initiatives as they emerge across the launch lifecycle, flexing capacity to address high-priority needs across market access workstreams in real time.

Qualifications & Experience

•Market Access Expertise: 7+ years in US Biotech/Pharma with deep experience in Payer Marketing, Patient Support Services, Pricing and Contracting Strategy, HEOR, and/or Launch Excellence.

•Portfolio Complexity: Proven ability to manage access strategies for multiple indications or products simultaneously

•Launch Execution: Direct experience managing the 'critical window' of pre-approval deliverables and Day-1 readiness.

•Cross-functional Leadership: Ability to collaborate and contextualize trade-offs with medical, legal, and regulatory for MMRC/PRB reviews.

•Communication: Exceptional ability to translate clinical and economic data into payer value communications and strategy documents.

•Vendor Management: Experience managing external agencies and vendors end-to-end — including scoping, contracting, directing deliverables, and ensuring on-time, on-strategy outputs.

•Rare Disease / Specialty Experience: Familiarity with rare or ultra-rare disease access dynamics is preferred.

The Impact

• In this role, you will be the primary driver of the execution steps that define our market success. By closing the gap on critical pre-approval deliverables, you ensure our breakthrough therapy is positioned for immediate uptake and long-term success.